Literature DB >> 19562803

2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease.

Jane A English1, Patrick Dicker, Melanie Föcking, Michael J Dunn, David R Cotter.   

Abstract

The mechanisms underlying white matter changes in psychiatric disease are not known. We aimed to characterise the differential protein expression in deep white matter from the dorsolateral prefrontal cortex from 35 schizophrenia, 35 bipolar disorder, and 35 control subjects, from the Stanley Array Collection. We used 2-D DIGE to profile for protein expression changes in the brain. We found 70 protein spots to be significantly differentially expressed between disease and control subjects (ANCOVA, p<0.05), 46 of which were subsequently identified by LC-MS/MS. The proteins identified included novel disease candidates as well as proteins that have previously been reported as abnormal in schizophrenia, thus reinforcing their association with the disease. Furthermore, we confirmed the direction of change for three proteins using ELISA, namely neurofilament-light, amphiphysin II, and Rab-GDP-alpha, in a subset of the Stanley Array Collection. In addition, altered expression of neurofilament-light, amphiphysin II, and Rab-GDP-alpha was not observed in the cortex of mice chronically treated with haloperidol, making it less likely that these alterations are a consequence of neuroleptic medication. The data presented here strongly suggest disruption of the cytoskeleton and its associated signal transduction proteins in schizophrenia, and to a lesser extent in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562803     DOI: 10.1002/pmic.200900015

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  58 in total

1.  Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome.

Authors:  Heather D VanGuilder; Han Yan; Julie A Farley; William E Sonntag; Willard M Freeman
Journal:  J Neurochem       Date:  2010-03-31       Impact factor: 5.372

Review 2.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

3.  Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia.

Authors:  Daniel Martins-de-Souza; Maria Lebar; Christoph W Turck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-19       Impact factor: 5.270

4.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

Review 5.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

6.  Regional differences in expression of β-tubulin isoforms in schizophrenia.

Authors:  Mark S Moehle; Richard F Luduena; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2012-01-20       Impact factor: 4.939

Review 7.  Extracellular matrix proteomics in schizophrenia and Alzheimer's disease.

Authors:  Manveen K Sethi; Joseph Zaia
Journal:  Anal Bioanal Chem       Date:  2016-09-06       Impact factor: 4.142

Review 8.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

9.  Identification of targeted analyte clusters for studies of schizophrenia.

Authors:  Tammy M K Cheng; Yu-En Lu; Paul C Guest; Hassan Rahmoune; Laura W Harris; Lan Wang; Dan Ma; Victoria Stelzhammer; Yagnesh Umrania; Matt T Wayland; Pietro Lió; Sabine Bahn
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

10.  The role of proteomics in depression research.

Authors:  Daniel Martins-de-Souza; Laura W Harris; Paul C Guest; Christoph W Turck; Sabine Bahn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-09       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.